COVID-19 Frequently Asked Questions 


ARE CLINICS IN THE ESCREEN™ NETWORK MINIMIZING THE RISK OF EXPOSURE TO COVID-19?

Clinics in eScreen’s network are being advised to take precautions to minimize the risk of exposure to COVID-19 to donors and patients and follow guidance from the Centers for Disease Control and other healthcare authorities.

These precautions include, for example, screening donors over the phone or in-person to detect potential COVID-19 cases and implementing enhanced cleaning protocols at their facilities.


DO CLINICS IN ESCREEN’S NETWORK TEST FOR COVID-19?

eScreen does not perform or arrange diagnostic testing for COVID-19. Clinics in eScreen’s network may perform or arrange diagnostic testing for COVID-19 as well as additional services that are separate from the drug testing and occupational health services those clinics provide for eScreen. eScreen does not track the availability of these services, including COVID-19 diagnostic testing.


WHAT DOES ESCREEN DO IF A CLINIC IN ITS NETWORK IS UNABLE TO PROVIDE SERVICES DUE TO COVID-19-RELATED CONCERNS?

eScreen continuously updates its roster of clinics available to provide services to you in our scheduling tool based on information those clinics share with eScreen. If a clinic informs eScreen that it is not available to perform a particular service, then eScreen will update its scheduling tool by removing that clinic from the roster of clinics available to perform that service.

Before sending the donor to the clinic you selected, we recommend that you call the clinic to confirm that it will perform the test or service you ordered at the desired time.


IS THE FEDERAL MOTOR CARRIER SAFETY ADMINISTRATION (FMCSA) MAKING ANY ANNOUNCEMENTS OR CHANGES RELATED TO COVID-19?

In response to COVID-19, Federal Motor Carrier Safety Administration (FMCSA) is making announcements related to regulation changes during the national emergency. 

Visit the links below to view some of these announcements and consider subscribing to FMCSA email updates to stay current on changes as they happen. 

https://www.fmcsa.dot.gov/emergency/fmcsa-cdl-waiver-32420

https://www.transportation.gov/odapc/compliance-with-dot-drug-and-alcohol-testing-regulations

https://www.fmcsa.dot.gov/COVID-19


HOW CAN COLLECTED SPECIMENS BE HELD AT A COLLECTION FACILITY IN THE EVENT OF SUPPLY LINE DISRUPTION?

In the event of supply line disruption requiring a collection facility to hold specimens for an extended period of time, urine specimens in plastic vials and oral fluid specimens collected using Intercept or Quantisal devices may be kept at room temperature for up to 7 days. If longer storage is required, place specimens into a secure refrigeration unit at 2 to 8 degrees C for up to 4 weeks.